Disturbance of the Intestinal Microbiota by Temocillin vs Cefotaxime in Treatment of Febrile Urinary Tract Infections
Status:
Completed
Trial end date:
2019-08-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the ecological impact on the intestinal microbiota and compare the
safety and efficacy of temocillin compared to cefotaxime, in empiric treatment of febrile
UTI. Half of participants will receive temocillin and the other half will receive cefotaxime.